© 2020 MJH Life Sciences and Center for Biosimilars®. All rights reserved.
© 2020 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
October 28, 2020
Arnold Ventures suggests ways the FDA and other governmental entities can get more biosimilars into circulation, faster.
October 22, 2020
Overcoming biosimilar uptake barriers will take collaboration and policy change by hospitals, infusion clinics, and health plans, presenters said at the Academy of Managed Care Pharmacy Nexus 2020 Virtual conference.
October 19, 2020
Reviewers found that costs of reference infliximab and its biosimilars make it the most cost-effective therapy for ulcerative colitis (UC) among targeted immune modulators.
October 17, 2020
Before its acquisition this year, Dean Foods attempted a specialty drug carve-out to save with biosimilars and generics.